Biosimilar Use, Cost Trends In Medicare Part B Will Be Examined By HHS Inspector General

 
• By Cathy Kelly
  
magnified money
OIG Will Investigate Extent Of Savings From Biosimilars • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products